Memnon Lysandrou
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Harnessing the immunomodulatory properties of HLA-G for advanced immunotherapies.
Journal: Frontiers in immunology
Published: September 30, 2025
Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: September 19, 2025
Strategies to enhance anti-leukaemia immunotherapy.
Journal: Current opinion in pharmacology
Published: September 30, 2024
Regulatory T cell therapy for Graft-versus-Host Disease.
Journal: Bone marrow transplantation
Published: September 01, 2024
Advances in cell therapy: progress and challenges in hematological and solid tumors.
Journal: Trends in pharmacological sciences
Published: August 12, 2024
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells.
Journal: Journal of visualized experiments : JoVE
Published: October 23, 2023
Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analyses.
Journal: Frontiers in immunology
Published: June 06, 2023
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming.
Journal: Cancers
Published: February 21, 2023
Study protocol: Phase I/II trial of induced HLA-G+ regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor.
Journal: Frontiers in medicine
Published: February 15, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026